Accessibility Menu
 
Australis Capital logo

Australis Capital

(OTC) AUSAF

Current Price$0.00
Market CapN/A
Since IPO (2018)-100%
5 Year-100%
1 Year-99%
1 Month-99%

Australis Capital Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$6.37M

Net Income (TTM)

$18.40M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-60029.17 (Low)

Price

$0.00

Volume

28

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

AUSAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Australis Capital

Industry

Pharmaceuticals

CEO

Terry Booth

Headquarters

Las Vegas, NV 89119, US

AUSAF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-3%

Net Income Margin

-7%

Return on Equity

0%

Return on Capital

-48%

Return on Assets

-99%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

28

Short Interest

0.00%

Avg. Volume

3.24K

Financials (TTM)

Gross Profit

$3.97M

Operating Income

$19.38M

EBITDA

$14.13M

Operating Cash Flow

$11.32M

Capital Expenditure

$0.00

Free Cash Flow

$11.32M

Cash & ST Invst.

$581.57K

Total Debt

$2.45M

Australis Capital Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2021YOY CHG

Revenue

$3.10K

+575.8%

Gross Profit

$1.73K

+7200.4%

Gross Margin

55.67%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

18

N/A

Net Income

$31.72K

-101.0%

EBITDA

$6.70M

-317.8%

Quarterly Fundamentals

Name
Q4 2021YOY CHG

Net Cash

$727.69

-82.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$2.45K

-99.8%

Short Term Debt

$0.00

-100.0%

Return on Assets

-98.98%

N/A

Return on Invested Capital

-48.49%

N/A

Free Cash Flow

$5.34K

-228.6%

Operating Cash Flow

$5.37K

-309.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IONKFIonic Brands Corp.
$0.00+0.00%
CBIHCannabis Bioscience International Holdings, Inc.
$0.00-20.00%
LOBEFLobe Sciences Ltd.
$0.04-15.09%
TWSITristar Wellness Solutions Inc.
$0.06+3.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
IMAImageneBio
$5.34+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.66-0.01%
SKYQSky Quarry
$17.75+0.41%

Questions About AUSAF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.